Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
IGF1R
REST API REST API
Homo sapiens
IGF1R is differentially expressed in 362 experiments: 145 organism parts: liver, prostate, ... (143 more);, 228 disease states: normal, glioblastoma, ... (226 more);, 117 cell types 520 cell lines 51 compound treatments and 97 other conditions.
Synonyms CD221, MGC18216, JTK13, IGFIR, IGFR
Orthologs F1NG99_CHICK (Gallus gallus)   igf1rb (Danio rerio)   IGF1R_BOVIN (Bos taurus)   Igf1r (Mus musculus)   igf1ra (Danio rerio)   Igf1r (Rattus norvegicus)   InR (Drosophila melanogaster)   igf1r (Xenopus laevis)   Q6QHH2_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term establishment of cell polarity, plasma membrane, protein binding, positive regulation of cell proliferation, membrane, insulin binding, insulin receptor binding, metal ion binding, insulin-like growth factor receptor signaling pathway, protein tyrosine kinase activity, insulin receptor signaling pathway, insulin receptor substrate binding, anti-apoptosis, transmembrane receptor protein tyrosine kinase signaling pathway, insulin-like growth factor binding, identical protein binding, ATP binding, neuron projection, microsome, neuron projection development, integral to plasma membrane, positive regulation of DNA replication, receptor activity, nucleotide binding, immune response, protein serine/threonine kinase activity, transmembrane receptor protein tyrosine kinase activity, negative regulation of protein kinase B signaling cascade, axonogenesis, integral to membrane, negative regulation of MAPKKK cascade, brain development, signal transduction, organ morphogenesis, protein kinase activity, caveola, response to vitamin E, exocrine pancreas development, mammary gland development, positive regulation of cell migration, positive regulation of anti-apoptosis, positive regulation of cytokinesis, insulin-like growth factor I binding, protein tetramerization, prostate gland epithelium morphogenesis, male sex determination, positive regulation of MAPKKK cascade, positive regulation of protein kinase B signaling cascade, positive regulation of DNA metabolic process, protein heterooligomerization, protein autophosphorylation, protein phosphorylation, phosphatidylinositol-mediated signaling, phosphatidylinositol 3-kinase cascade, phosphatidylinositol 3-kinase binding, positive regulation of steroid hormone biosynthetic process, insulin-like growth factor-activated receptor activity
InterPro Term Furin-like_Cys-rich_dom, Prot_kinase_cat_dom, EGF_rcpt_L, Furin_repeat, Tyr_kinase_insulin-like_rcpt, Ser/Thr_kinase_dom, Tyr_kinase_cat_dom, Ser-Thr/Tyr_kinase, Se/Thr_kinase-like_dom, Fibronectin_type3
UniProt Accession C9J5X1, P08069
Gene-Disease Assocation INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO
Search EB-eye ENSG00000140443
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-17189, E-GEOD-803, E-GEOD-15765, E-GEOD-6573, E-GEOD-1577, ... (32 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-5258, E-GEOD-4525, E-MEXP-1006, E-GEOD-18005, E-GEOD-2450, ... (52 experiments)

Factor Value U/D Experiments
MCF-7
4
E-GEOD-3529, E-GEOD-20081, E-GEOD-5823, E-GEOD-19639
HL-60
3
E-GEOD-24147, E-MTAB-37, E-GEOD-5258
LNCaP
3
E-GEOD-14990, E-GEOD-14464, E-GEOD-762
A549
2
E-GEOD-3202, E-GEOD-6013
BT-474
2
E-GEOD-5823, E-GEOD-3529
MCF7
2
E-GEOD-5258, E-MTAB-37
514 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-3920, E-MEXP-750, E-TABM-34, E-GEOD-2822, ... (54 experiments)

Factor Value U/D Experiments
epithelial cell
1
3
E-MEXP-1327, E-GEOD-4483, E-MEXP-2034, E-GEOD-10797
1
2
E-TABM-145, E-TABM-130
endothelial cell
1
2
E-GEOD-19240, E-GEOD-3920, E-GEOD-3998
adrenal cortex cell
1
E-MEXP-669
effector memory T cell
1
E-GEOD-3982
dendritic cell
1
E-MEXP-2019
111 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-GEOD-1577, E-MEXP-2280, ... (69 experiments)

Factor Value U/D Experiments
prostate carcinoma
4
E-MEXP-2034, E-MTAB-62, E-GEOD-96, E-GEOD-7307
lung adenocarcinoma
3
E-MTAB-37, E-MTAB-62, E-MEXP-231
acute lymphoblastic leukemia
2
E-MTAB-62, E-MTAB-37
colon carcinoma
2
E-MTAB-62, E-MTAB-37
control
2
E-GEOD-16363, E-GEOD-8121
gastric carcinoma
2
E-GEOD-15460, E-MTAB-37
222 more value(s).


Compound treatment

studied in E-GEOD-4668, E-GEOD-5741, E-GEOD-1417, E-GEOD-5824, E-GEOD-7708, ... (31 experiments)

Factor Value U/D Experiments
glucose
1
E-MEXP-941
interleukin-4 (Homo sapiens) + anti-CD40
1
E-GEOD-7307
dihydrotestoterone
1
E-GEOD-7708
sapphyrin PCI-2052
1
E-GEOD-6400
-
1
1
E-MEXP-2645
LDL
1
E-GEOD-5741
45 more value(s).


Age at diagnosis

studied in E-GEOD-3494

Factor Value U/D Experiments
36
2
1
E-GEOD-3494
41
2
1
E-GEOD-3494


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd1a
studied in E-GEOD-22601

cd34
studied in E-GEOD-22601

cd4
studied in E-GEOD-22601

cd8
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-GEOD-1729

Classifier
studied in E-GEOD-3493

Clinical history
studied in E-GEOD-19420, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-2171, ... (8 experiments)

Clinical info
studied in E-GEOD-19743, E-GEOD-19246, E-MEXP-1251, E-GEOD-21374, E-GEOD-1563, ... (13 experiments)

Clinical treatment
studied in E-GEOD-5377, E-GEOD-1743, E-GEOD-2171, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-19743, E-GEOD-1614, E-GEOD-20033, E-MEXP-2359, E-GEOD-2666, ... (11 experiments)

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-TABM-577, E-GEOD-22148, E-MEXP-2280, ... (9 experiments)

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-4086

Er
studied in E-GEOD-20194, E-GEOD-16716

Er ihc
studied in E-GEOD-21653

Estrogen receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-4922, E-GEOD-20194, E-GEOD-16716 ... (5 experiments)

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-21589, E-GEOD-16363

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, ... (10 experiments)

Genotype
studied in E-GEOD-17476, E-GEOD-2466, E-GEOD-22593, E-GEOD-18005, E-TABM-601, ... (14 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-GEOD-22278, E-GEOD-10315, E-GEOD-20505, E-TABM-263, ... (15 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Her2 status
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276, E-GEOD-20194, E-GEOD-16716

Individual
studied in E-TABM-325, E-MTAB-197, E-TABM-740, E-GEOD-974, E-MEXP-2069, ... (40 experiments)

Infection
studied in E-GEOD-2405, E-GEOD-12108, E-GEOD-12254, E-MEXP-561, E-GEOD-980, ... (6 experiments)

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-22056, E-GEOD-12662

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Light
studied in E-GEOD-1725

Localisation of metastases
studied in E-GEOD-22541

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-AFMX-1, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

P53 ihc
studied in E-GEOD-21653

Pcr vs rd
studied in E-GEOD-20194, E-GEOD-16716

Performer
studied in E-GEOD-2004, E-LGCL-5

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-26495, E-GEOD-19703, E-GEOD-21750, E-GEOD-1460, E-GEOD-17636, ... (6 experiments)

Population
studied in E-GEOD-4922, E-GEOD-4342

Pr ihc
studied in E-GEOD-21653

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19246, E-GEOD-1343, ... (6 experiments)

Replicate
studied in E-GEOD-10797, E-GEOD-17204

Rna integrity
studied in E-TABM-325

RNAi
studied in E-MEXP-2115, E-MEXP-1509, E-MEXP-101, E-MEXP-548, E-GEOD-3697, ... (7 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-21374, E-GEOD-17400

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-2508, E-GEOD-19069, E-GEOD-2466, E-GEOD-8052, E-GEOD-7307 ... (5 experiments)

Sirna
studied in E-GEOD-21575, E-GEOD-21574

Stimulation
studied in E-GEOD-4883, E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-MEXP-1996

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-GEOD-1926, E-TABM-276

Tissue
studied in E-GEOD-30573

Transfection
studied in E-GEOD-14680

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-33562, E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-19815, ... (6 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-4271, E-TABM-43, E-GEOD-1561, E-GEOD-4922 ... (5 experiments)

Tumor size
studied in E-GEOD-8167, E-GEOD-3494

Vehicle
studied in E-GEOD-5258

Processing time: 0.548 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM